Canada Diabetes Market Report: 2018-2023
IMARC’s new report “Canada Diabetes Market Report: 2018-2023” provides an analytical and statistical insight into the Canada diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in Canada. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Canada diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the Canada diabetes market in any form.What we have achieved in this report:
Comprehensive situation analysis of the Canada diabetes epidemiology and its dynamics:
Focus of the Analysis:
Historical, current and future prevalence of diabetes in Canada
Historical, current and future prevalence of type-1 and type-2 diabetes in Canada
Historical, current and future prevalence of diabetes in the urban and rural regions in Canada
Historical, current and future prevalence of diabetes among males and females in Canada
Historical, current and future prevalence of diabetes among various age groups in Canada
Historical, current and future diagnosis rates for diabetes in Canada
Historical, current and future drug treatment rates for diabetes in Canada
Comprehensive situation analysis of the Canadian Oral Antidiabetics market and its dynamics:
Focus of the Analysis:
Performance of the Oral Antidiabetics market in Canada
Performance of key classes
Performance of key players
Market outlook
Comprehensive situation analysis of the Canadian Insulin market and its dynamics:
Focus of the Analysis:
Performance of the Insulin market in Canada
Performance of key classes
Performance of key players
Market outlook
Comprehensive situation analysis of the Canada diabetes epidemiology and its dynamics:
Focus of the Analysis:
Historical, current and future prevalence of diabetes in Canada
Historical, current and future prevalence of type-1 and type-2 diabetes in Canada
Historical, current and future prevalence of diabetes in the urban and rural regions in Canada
Historical, current and future prevalence of diabetes among males and females in Canada
Historical, current and future prevalence of diabetes among various age groups in Canada
Historical, current and future diagnosis rates for diabetes in Canada
Historical, current and future drug treatment rates for diabetes in Canada
Comprehensive situation analysis of the Canadian Oral Antidiabetics market and its dynamics:
Focus of the Analysis:
Performance of the Oral Antidiabetics market in Canada
Performance of key classes
Performance of key players
Market outlook
Comprehensive situation analysis of the Canadian Insulin market and its dynamics:
Focus of the Analysis:
Performance of the Insulin market in Canada
Performance of key classes
Performance of key players
Market outlook
1 PREFACE
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 DIABETES DISEASE OVERVIEW
5.1 What is Diabetes?
5.2 Diabetes Diagnosis and Treatment
5.2.1 Diagnosis
5.2.2 Treatment
5.3 Diabetes Complications
6 CANADA DIABETES EPIDEMIOLOGY
6.1 Diabetes Population and Prevalence Rates
6.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
6.3 Population and Prevalence Rates by Region
6.4 Population and Prevalence Rates by Gender
6.5 Population and Prevalence Rates by Age Group
7 CANADA DIABETES MARKET
7.1 Market Overview
7.2 Market Performance
7.3 Market Forecast
7.4 SWOT Analysis
7.4.1 Strengths
7.4.2 Weaknesses
7.4.3 Opportunities
7.4.4 Threats
7.5 Value Chain Analysis
7.6 Porter’s Five Forces Analysis
7.6.1 Overview
7.6.2 Bargaining Power of Buyers
7.6.3 Bargaining Power of Suppliers
7.6.4 Degree of Competition
7.6.5 Threat of New Entrants
7.6.6 Threat of Substitutes
7.7 Market Breakup by Segment
7.7.1 Canada Oral Antidiabetics Market
7.7.1.1 Historical Market Trends
7.7.1.2 Market Breakup by Class
7.7.1.3 Market Shares of Key Players
7.7.1.4 Market Forecast
7.7.2 Canada Insulin Market
7.7.2.1 Historical Market Trends
7.7.2.2 Market Breakup by Class
7.7.2.3 Market Shares of Key Players
7.7.2.4 Market Forecast
8 COMPETITIVE LANDSCAPE
8.1 Competitive Structure
8.2 Profiles of Key Players
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 DIABETES DISEASE OVERVIEW
5.1 What is Diabetes?
5.2 Diabetes Diagnosis and Treatment
5.2.1 Diagnosis
5.2.2 Treatment
5.3 Diabetes Complications
6 CANADA DIABETES EPIDEMIOLOGY
6.1 Diabetes Population and Prevalence Rates
6.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
6.3 Population and Prevalence Rates by Region
6.4 Population and Prevalence Rates by Gender
6.5 Population and Prevalence Rates by Age Group
7 CANADA DIABETES MARKET
7.1 Market Overview
7.2 Market Performance
7.3 Market Forecast
7.4 SWOT Analysis
7.4.1 Strengths
7.4.2 Weaknesses
7.4.3 Opportunities
7.4.4 Threats
7.5 Value Chain Analysis
7.6 Porter’s Five Forces Analysis
7.6.1 Overview
7.6.2 Bargaining Power of Buyers
7.6.3 Bargaining Power of Suppliers
7.6.4 Degree of Competition
7.6.5 Threat of New Entrants
7.6.6 Threat of Substitutes
7.7 Market Breakup by Segment
7.7.1 Canada Oral Antidiabetics Market
7.7.1.1 Historical Market Trends
7.7.1.2 Market Breakup by Class
7.7.1.3 Market Shares of Key Players
7.7.1.4 Market Forecast
7.7.2 Canada Insulin Market
7.7.2.1 Historical Market Trends
7.7.2.2 Market Breakup by Class
7.7.2.3 Market Shares of Key Players
7.7.2.4 Market Forecast
8 COMPETITIVE LANDSCAPE
8.1 Competitive Structure
8.2 Profiles of Key Players
LIST OF FIGURES
Figure 1: The Impact of Diabetes in the Human Body
Figure 2: Diabetes Complications
Figure 3: Global: Breakup of Diabetes Patients by Region, (in %) 2017 & 2023
Figure 4: Body Mass Index and Relative risk of Type-2 Diabetes
Figure 5: Canada: Total Number of Diabetes Patients (in 000), 2010-2017
Figure 6: Canada: Total Number of Diabetes Patients Forecast (in 000), 2018-2023
Figure 7: Canada (Type1 & Type2): Total Number of Diabetes Patients (in 000), 2010-2017
Figure 8: Canada (Type1 & Type2): Total Number of Diabetes Patients (in 000), 2018-2023
Figure 9: Canada (Urban & Rural): Total Number of Diabetes Patients (in 000), 2010-2017
Figure 10: Canada (Urban & Rural): Total Number of Diabetes Patients (in 000), 2018-2023
Figure 11: Canada (Male & Female): Total Number of Diabetes Patients (in 000), 2010-2017
Figure 12: Canada (Male & Female): Total Number of Diabetes Patients (in 000), 2018-2023
Figure 13: Canada: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in 000), 2010-2017
Figure 14: Canada: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in 000), 2018-2023
Figure 15: Canada: Diabetes Drug Industry Overview
Figure 16: Canada: Diabetes Drug Market (in Million US$), 2010-2017
Figure 17: Canada: Diabetes Drug Market Forecast (in Million US$), 2018-2023
Figure 18: Canada: Diabetes Drug Market: SWOT Analysis
Figure 19: Canada: Diabetes Drug Market: Value Chain Analysis
Figure 20: Canada: Diabetes Drug Market: Porters Five Forces Analysis
Figure 21: Canada: Diabetes Drug Market: Breakup of Insulin and Oral Antidiabetics (in %), 2010-2017
Figure 22: Canada: Diabetes Drug Market Forecast: Breakup of Insulin and Oral Antidiabetics (in %), 2018-2023
Figure 23: Canada: Oral Antidiabetics Market: (in Million US$), 2010-2017
Figure 24: Canada: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2010 & 2017
Figure 25: Canada: Oral Anti-diabetics Market: Sales Share of Key Players (in %)
Figure 26: Canada: Oral Antidiabetics Market: (in Million US$), 2018-2023
Figure 27: Canada: Insulin Market, (in Million US$), 2010-2017
Figure 28: Canada: Breakup of Insulin Market by Class (in %), 2010 & 2017
Figure 29: Canada: Insulin Market: Sales Share of Key Players (in %)
Figure 30: Canada: Insulin Market Forecast (in Million US$), 2018-2023
Figure 1: The Impact of Diabetes in the Human Body
Figure 2: Diabetes Complications
Figure 3: Global: Breakup of Diabetes Patients by Region, (in %) 2017 & 2023
Figure 4: Body Mass Index and Relative risk of Type-2 Diabetes
Figure 5: Canada: Total Number of Diabetes Patients (in 000), 2010-2017
Figure 6: Canada: Total Number of Diabetes Patients Forecast (in 000), 2018-2023
Figure 7: Canada (Type1 & Type2): Total Number of Diabetes Patients (in 000), 2010-2017
Figure 8: Canada (Type1 & Type2): Total Number of Diabetes Patients (in 000), 2018-2023
Figure 9: Canada (Urban & Rural): Total Number of Diabetes Patients (in 000), 2010-2017
Figure 10: Canada (Urban & Rural): Total Number of Diabetes Patients (in 000), 2018-2023
Figure 11: Canada (Male & Female): Total Number of Diabetes Patients (in 000), 2010-2017
Figure 12: Canada (Male & Female): Total Number of Diabetes Patients (in 000), 2018-2023
Figure 13: Canada: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in 000), 2010-2017
Figure 14: Canada: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in 000), 2018-2023
Figure 15: Canada: Diabetes Drug Industry Overview
Figure 16: Canada: Diabetes Drug Market (in Million US$), 2010-2017
Figure 17: Canada: Diabetes Drug Market Forecast (in Million US$), 2018-2023
Figure 18: Canada: Diabetes Drug Market: SWOT Analysis
Figure 19: Canada: Diabetes Drug Market: Value Chain Analysis
Figure 20: Canada: Diabetes Drug Market: Porters Five Forces Analysis
Figure 21: Canada: Diabetes Drug Market: Breakup of Insulin and Oral Antidiabetics (in %), 2010-2017
Figure 22: Canada: Diabetes Drug Market Forecast: Breakup of Insulin and Oral Antidiabetics (in %), 2018-2023
Figure 23: Canada: Oral Antidiabetics Market: (in Million US$), 2010-2017
Figure 24: Canada: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2010 & 2017
Figure 25: Canada: Oral Anti-diabetics Market: Sales Share of Key Players (in %)
Figure 26: Canada: Oral Antidiabetics Market: (in Million US$), 2018-2023
Figure 27: Canada: Insulin Market, (in Million US$), 2010-2017
Figure 28: Canada: Breakup of Insulin Market by Class (in %), 2010 & 2017
Figure 29: Canada: Insulin Market: Sales Share of Key Players (in %)
Figure 30: Canada: Insulin Market Forecast (in Million US$), 2018-2023
LIST OF TABLES
Table 1: Diagnosis of Diabetes
Table 2: Global: Diabetes Population Breakup by Country (in 000’s), 2017 & 2023
Table 3: Canada: Total Prevalence & Number of Diabetes Patients, 2010, 2017 & 2023
Table 4: Canada (Type1 & Type2): Total Prevalence & Number of Diabetes Patients, 2010, 2017 & 2023
Table 5: Canada (Urban & Rural): Total Prevalence & Number of Diabetes Patients, 2010, 2017 & 2023
Table 6: Canada (Male & Female): Total Prevalence & Number of Diabetes Patients, 2010, 2017 & 2023
Table 7: Canada: Total Prevalence & Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (In Millions), 2010, 2017 & 2023
Table 8: Canada: Diabetes Drug Market: Competitive Structure
Table 1: Diagnosis of Diabetes
Table 2: Global: Diabetes Population Breakup by Country (in 000’s), 2017 & 2023
Table 3: Canada: Total Prevalence & Number of Diabetes Patients, 2010, 2017 & 2023
Table 4: Canada (Type1 & Type2): Total Prevalence & Number of Diabetes Patients, 2010, 2017 & 2023
Table 5: Canada (Urban & Rural): Total Prevalence & Number of Diabetes Patients, 2010, 2017 & 2023
Table 6: Canada (Male & Female): Total Prevalence & Number of Diabetes Patients, 2010, 2017 & 2023
Table 7: Canada: Total Prevalence & Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (In Millions), 2010, 2017 & 2023
Table 8: Canada: Diabetes Drug Market: Competitive Structure
